Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011854 (type 1 diabetes)
 20,749 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

To evaluate the pancreatic amylin in the pathogenesis of non-insulin-dependent diabetes mellitus (NIDDM), we determined the pancreatic amylin (IRA) and insulin (IRI) contents of pancreata obtained at autopsy from diabetics and nondiabetics. IRA was extracted from the tail of the pancreas using formic acid and assayed with a human amylin kit. Following gel filtration of amylin on a Sephadex G-50 column, it was eluted in a similar fraction to insulin. The pancreatic IRA content was significantly higher (p < 0.01) in NIDDM subjects compared with nondiabetics, with the mean values being 4.25 +/- 1.62 and 0.085 +/- 0.022 microgram/g, respectively. The IRA content of two IDDM pancreata was low. No significant relationship was found between the IRA and the IRI contents or between the IRA content and the duration of diabetes. However, there was a tendency for the IRA content to increase in longstanding diabetes. Men had a significantly higher pancreatic IRA content than women. The four subjects with very high IRA levels ( > 10 micrograms/g) were all elderly men with a long duration of diabetes. Thus, although the pancreatic amylin content was increased in NIDDM, no significant relationship to the clinical features of the disease was found.
 ...
PMID:Pancreatic amylin content in human diabetic subjects and its relation to diabetes. 857 86